Claudio Ruffmann

Parkinson's disease

The prediagnostic phase of Parkinson's disease

Neurofilament light chain as a biomarker in neurological disorders

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Irritable bowel syndrome

Gut dysfunction in Parkinson's disease

Epidemiology of Parkinson’s disease

Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

Recommendation for a definition of acute symptomatic seizure

The epidemiology of Parkinson's disease: risk factors and prevention

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies

Alzheimer's disease

Diagnosis and Treatment of Parkinson Disease

ILAE Official Report: A practical clinical definition of epilepsy

Constipation: an emerging risk factor for Parkinson's disease?

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder

Epileptogenic drugs: a systematic review

Delineating nonmotor symptoms in early Parkinson's disease and first‐degree relatives

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

Gut Feelings About α‐Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD